se of rotational thromboelastometry (ROTEM) guided blood product utilisation in cirrhotic patients undergoing interventional procedures.

Not Applicable

• Conditions: chronic liver disease; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12619001234101
• Lead Sponsor: Flinders Medical Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-09-06
• Last Update Posted: 30 September 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Aged greater than or equal to 18 years
Able to give informed consent
Patients with coagulopathy (INR greater than or equal to 1.8 OR Platelet count less than or equal to 50,000) who require procedures with moderate to high risk of bleeding

Exclusion Criteria

Known overt encephalopathy or cognitive impairment from other aetiologies
Non-English speakers

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of patients in each group requiring blood products.<br><br>3.5ml of blood is to be collected into a citrate tube, which will be processed in the ROTEM analyzer on the same day of the procedure. Only one sample is required. Patients will then receive blood products as per the ROTEM algorithm. <br><br>Patients in each arm who received blood products (e.g red cells, FFP, platelets, cryoprecipitate) will then be tallied.[On day of intervention]